4//SEC Filing
Singhal Anil K. 4
Accession 0000950170-25-025022
CIK 0001785530other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:57 PM ET
Size
5.3 KB
Accession
0000950170-25-025022
Insider Transaction Report
Form 4
Singhal Anil K.
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-19+45,000→ 45,000 totalExercise: $1.40Exp: 2035-02-18→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 19, 2025. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001982984
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:57 PM ET
- Size
- 5.3 KB